Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology

Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology

Source: 
Xconomy
snippet: 

Inside of a cell, some proteins and RNA are concentrated in liquid droplets that assemble in formation during a variety of cellular functions. Dewpoint Therapeutics is making headway understanding the role these droplets play in disease, and that work now has Bayer as a research partner.

Bayer and Dewpoint on Thursday announced a research agreement that encompasses this liquid droplet science.